Presepsin a 'Robust' Biomarker of Early-Onset Sepsis
(MedPage Today) -- Presepsin holds promise as a biomarker for early-onset sepsis (EOS), a systematic review and meta-analysis confirmed.
Across a dozen clinical trials, presepsin had a pooled sensitivity of 0.93 for the primary analysis of culture...
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news
More News: Clinical Trials | Pediatrics